マサチューセッツ州における肺疾患の臨床試験
マサチューセッツ州内の拠点で、肺疾患に関する15件の研究が参加者を募集しています。
マサチューセッツ州内の都市
公式研究テキスト（英語）
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Dana-Farber Cancer Institute, Boston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Brigham and Women's Hospital, Boston
- Lucida Clinical Trials, New Bedford
- University of Massachusetts Chan Medical School, Worcester
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Brigham and Women's Hospital, Boston
- Clinical Trials Center, Boston
- Clinical Trials Hub, Boston
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Brigham and Women's Hospital, Boston
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Boston Medical Center, Boston
- Lahey Hospital & Medical Center, Burlington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Infinity Medical Research, North Dartmouth
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/03更新 · NCT07284602A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Boston
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Beth Israel Deaconess Medical Center, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT05967689A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Boston
被験者募集中第2相
4歳〜11歳 · 全性別 · 2026/08/27更新 · NCT07525375BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/10更新 · NCT05922761A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT02984761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Dana-Farber Cancer Institute, Boston
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Brigham and Women's Hospital, Boston
被験者募集中
18歳以上 · 全性別 · 2025/09/29更新 · NCT04555161ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。